Moreover, consistent with the role of oxidative stress in pulmonary embolism, we found that the administration of luteolin significantly decreased MDA levels and increased SOD activity in plasma of mice with pulmonary embolism (Figure 6E). This evidence concerns the gene SOD1 and pulmonary embolism.